#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4408	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2460	525.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1553	1553	C	641	C	568	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6508	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3940	494.1	0	.	n	.	0	T695C	SNP	695	695	T	1230	1230	C	514	C,T,A	455,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6508	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3940	494.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1872	1872	A	554	A	497	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6508	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3940	494.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2506	2506	C	586	C,A	525,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6508	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3940	494.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3132	3132	T	593	T,G	525,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6508	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3940	494.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2580	2580	A	583	A,C	536,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	660	folP	852	852	100.0	folP.l15.c4.ctg.1	1908	102.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1239	1241	AGC	137;138;139	A;G;C	123;128;127	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1322	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3801	104.1	1	SNP	p	S91F	0	.	.	271	273	TCC	821	823	TCC	131;131;133	T;C;C	126;130;124	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1322	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3801	104.1	1	SNP	p	D95G	0	.	.	283	285	GAC	833	835	GAC	133;131;131	G;A;C	129;124;123	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1322	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3801	104.1	1	SNP	p	D95N	0	.	.	283	285	GAC	833	835	GAC	133;131;131	G;A;C	129;124;123	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	570	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1901	90.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	466	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1539	90.4	0	.	n	.	0	C187G	SNP	187	187	C	785	785	G	182	G	165	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1506	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3593	125.2	1	SNP	p	D86N	0	.	.	256	258	GAC	927	929	GAC	171;172;171	G,A;A;C	151,1;148;152	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1506	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3593	125.2	1	SNP	p	S87I	0	.	.	259	261	AGT	930	932	AGT	171;171;172	A,C;G;T,C	142,2;151;150,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1506	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3593	125.2	1	SNP	p	S87R	0	.	.	259	261	AGT	930	932	AGT	171;171;172	A,C;G;T,C	142,2;151;150,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1506	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3593	125.2	1	SNP	p	S87W	0	.	.	259	261	AGT	930	932	AGT	171;171;172	A,C;G;T,C	142,2;151;150,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1506	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3593	125.2	1	SNP	p	S88P	0	.	.	262	264	TCC	933	935	TCC	174;175;177	T;C,T;C	152;158,1;154	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1148	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3347	102.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1952	1954	GGC	123;123;122	G;G;C	112;104;106	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1419	1421	GCA	168;168;168	G;C,A;A	148;150,1;154	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1422	1424	ATC	170;170;170	A;T,C,A;C	156;155,1,1;158	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1434	1436	GTG	170;169;170	G;T;G	154;151;151	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1434	1436	GTG	170;169;170	G;T;G	154;151;151	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1938	1940	ACC	145;146;146	A,G;C;C,A	128,1;130;127,2	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1992	1994	GCG	141;141;142	G;C,G;G	120;110,2;110	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1992	1994	GCG	141;141;142	G;C,G;G	120;110,2;110	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2115	2117	GGC	129;130;129	G;G;C	110;113;110	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2124	2126	GGC	126;126;126	G;G;C,G	108;106;111,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1150	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2800	122.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2142	2144	CCG	127;126;125	C;C,A;G,C	107;111,1;105,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1352	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3417	117.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1760	1762	CTG	96;98;98	C;T;G	81;87;85	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	740	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2456	90.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	860	860	C	120	C,T	110,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	170	90.23	porB1a.l15.c17.ctg.1	1390	27.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1245	1247	AAT	10;10;10	A;A;T	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	170	90.23	porB1a.l15.c17.ctg.1	1390	27.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1248	1250	AAT	10;10;10	A;A;T	9;9;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	170	90.23	porB1a.l15.c17.ctg.1	1390	27.0	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1260	1262	GTT	10;10;10	G;T;T	10;9;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	170	90.23	porB1a.l15.c17.ctg.1	1390	27.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1272	1274	GCA	9;9;9	G;C;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	170	90.23	porB1a.l15.c17.ctg.1	1390	27.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1295	1297	GTA	8;8;8	G;T;A	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	170	90.23	porB1a.l15.c17.ctg.1	1390	27.0	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1304	1304	A	8	A	7	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	G38E	NONSYN	112	114	GGA	662	664	GAA	165;165;167	G,T;A;A,C	153,1;149;153,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	S46G	NONSYN	136	138	AGC	686	688	GGC	163;162;160	G;G;C	148;148;143	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	692	694	GGA	162;162;161	G;G;A	145;142;143	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	T87A	NONSYN	259	261	ACT	809	811	GCT	170;170;169	G;C;T,G	146;148;148,2	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	T89S	NONSYN	265	267	ACC	815	817	AGC	162;159;160	A;G;C	146;148;148	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	.	MULTIPLE	358	359	AA	907	908	CG	167;167	C;G	153;154	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	.	MULTIPLE	361	362	GA	910	912	CAG	166;164;164	C;A;G	152;151;152	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	N122K	NONSYN	364	366	AAC	914	916	AAA	164;163;161	A;A;A,C	150;151;148,2	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	K143E	NONSYN	427	429	AAA	977	979	GAA	164;164;163	G;A;A	149;151;144	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1001	1003	GCA	167;167;167	G;C;A	146;145;148	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1109	1111	CGA	162;162;163	C,A;G;A	144,1;146;149	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1193	1195	ACT	162;161;160	A;C;T	144;145;137	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	Y216H	NONSYN	646	648	TAT	1196	1198	CAT	160;160;160	C;A;T	143;142;142	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1202	1204	ATG	161;160;159	A,G,C;T;G	146,1,1;146;146	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	.	MULTIPLE	766	767	AC	1316	1318	GCA	153;152;152	G;C,T;A	141;135,1;139	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	W257R	NONSYN	769	771	TGG	1320	1322	CGG	150;150;150	C,A;G;G	134,1;140;137	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	0	.	p	.	0	S258fs	FSHIFT	772	772	A	1323	1323	A	150	A	135	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	1	SNP	p	G120K	1	.	.	358	360	AAG	907	909	CGG	167;167;167	C;G;G	153;154;146	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	1	SNP	p	D121N	0	.	.	361	363	GAC	910	913	CGC	166;164;164	C;G;C	152;152;150	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	854	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1927	131.1	1	SNP	p	A121D	1	.	.	361	363	GAC	910	913	CGC	166;164;164	C;G;C	152;152;150	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2646	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5246	150.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2192	2194	AAT	139;140;140	A;A;T,G	129;125;128,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	502	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1655	90.5	1	SNP	p	V57M	1	.	.	169	171	ATG	843	845	ATG	190;188;188	A;T;G	173;173;170	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
